VeriStrat® classifier for survival and time to progression in non-small cell lung cancer (NSCLC) patients treated with erlotinib and bevacizumab

✍ Scribed by Carbone, David P.; Salmon, J. Stuart; Billheimer, Dean; Chen, Heidi; Sandler, Alan; Roder, Heinrich; Roder, Joanna; Tsypin, Maxim; Herbst, Roy S.; Tsao, Anne S.

• Book ID: 119320313
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 182 KB
• Volume: 69
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/j.lungcan.2009.11.019